N/A
Completed N=25
WREX Outcome Study
Muscular Dystrophy · Arthrogryposis · spinal muscular atrophy
Source: ClinicalTrials.gov NCT02218593 ↗
Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Canadian Occupational Performance Measure (COPM) — 7.09 score on a scale
Summary
This study is to evaluate how the Wilmington Robotic Exoskeleton (WREX) is working for children who are using the WREX, or have used it in the past. The survey consists of a set of questions a) performed online and b) performed over the phone.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Canadian Occupational Performance Measure (COPM) |
7.09 | — |
Eligibility Criteria
Inclusion Criteria
- Neuromuscular disease
- Use the Wilmington Robotic Exoskeleton
Exclusion Criteria
- people who do not use the Wilmington Robotic Exoskeleton
Data sourced from ClinicalTrials.gov (NCT02218593). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.